Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... Aim. To study prevalence of resistance to acetylsalicylic acid, clopidogrel and dual resistance ..."
 
Vol 3, No 3 (2007) RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
"... The clinical, cell and genetic factors are distinguished among reasons for resistance ..."
 
Vol 6, No 4 (2010) CLOPIDOGREL PHARMACOGENETICS Abstract  similar documents
A. N. Meshkov
"... insufficient effect in some patients, ie they are resistant to clopidogrel. Genetic causes of resistance ..."
 
Vol 9, No 4 (2013) THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev
"... of the formation of the active clopidogrel metabolite, for efficacy and safety of this drug in cardiology practice ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... . Resistance to ASA, clopidogrel and DAT were detected. Endpoints included cases of repeated atherothrombotic ..."
 
Vol 9, No 3 (2013) TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN Abstract  similar documents
A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin
"... resistance to aspirin might result in treatment failure. Despite this concern, no clear definition of aspirin ..."
 
Vol 13, No 1 (2017) MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya
"... , антитромбоцитарная терапия, аспирин, клопидогрел, резистентность, контроль. Для цитирования: Пучиньян Н.Ф., Фурман Н ..."
 
Vol 4, No 2 (2008) ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov
"... Aim. To evaluate the incidence of acetylsalicylic acid (ASA) and clopidogrel resistance ..."
 
Vol 6, No 2 (2010) THE MODERN ASPECTS OF CLOPIDOGREL USE Abstract  similar documents
E. N. Dankovtseva, D. A. Zateyshchikov
"... The possibilities and evidence base of clopidogrel use in clinical practice are discussed. Data ..."
 
Vol 5, No 3 (2009) ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva
"... Aim. To study a rate of resistance to acetylsalicylic acid (ASA) and clopidogrel and clinical ..."
 
Vol 11, No 1 (2015) EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Andreev, D. A. Sychev
"... of clopidogrel, the association of residual platelet reactivity with clinical outcomes and a review ..."
 
Vol 7, No 1 (2011) THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS Abstract  similar documents
O. V. Gaisenok
"... in patients with cardioascular diseases are discussed. Role of clopidogrel in contemporary antiplatelet ..."
 
Vol 6, No 4 (2010) ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY? Abstract  similar documents
S. J. Martsevich
"... with clopidogrel is discussed. The reason of this resistance to clopidogrel therapy and possible ways to overcome ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
"... of carriership of at least one CYP4F2*3 allele on the risk of resistance to clopidogrel in patients with acute ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... .1 in the CYP2C19*1/*1 group vs 18.2±16.4 in the CYP2C19*1/*2 one (р=0.03). Clopidogrel laboratory resistance (P ..."
 
Vol 7, No 6 (2011) ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS Abstract  similar documents
L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo
"... Aim. To analyze the literary and own data about clopidogrel influence on platelets during ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... on the sensitivity and resistance to ASA. The indicators of vascularplatelet and plasma hemostasis were evaluated ..."
 
Vol 2, No 3 (2006) CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES Abstract  similar documents
P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian
"... with aspirin therapy or resistance to aspirin is independent predictor of high coronary risk ..."
 
Vol 3, No 4 (2007) RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi
"... atherothrombotic complications. Platelet ability to aggregation was assessed with laser aggregometer. Resistance ..."
 
Vol 14, No 5 (2018) Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case Abstract  similar documents
M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov
"...   for resistance to antiplatelet therapy with clopidogrel. The decrease in the effectiveness of prolonged therapy ..."
 
Vol 15, No 3 (2019) Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery Abstract  similar documents
A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein
"... with acetylsalicylic acid (ASA) resistance in patients with coronary heart disease after coronary bypass surgery (CABG ..."
 
Vol 10, No 6 (2014) СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY? Abstract  similar documents
S. Yu. Martsevich, A. Yu. Suvorov
"... Concomitant administration of clopidogrel and proton pump inhibitors (PPI), the possible influence ..."
 
Vol 9, No 1 (2013) POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
"... and induced flow cytofluorometry during antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... Введение. Полученные ранее данные свидетельствуют о наличии у клопидогрела не только ..."
 
Vol 13, No 5 (2017) INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION Abstract  similar documents
E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash
"... Aim. To study the effect of replacing clopidogrel with ticagrelor on endpoints of hospital period ..."
 
Vol 12, No 3 (2016) CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY Abstract  PDF (Eng)  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko
"... . Results. The ASA-resistance rate was 26.7%. The ASA-resistant patients as compared with ASA-sensitive ..."
 
Vol 5, No 5 (2009) EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi
"... and morphology of erythrocytes and to assess their changes during therapy with acetylsalicylic acid, emclopidogrel/em ..."
 
Vol 8, No 2 (2012) RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS Abstract  similar documents
A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova
"... Aim. To compare effects of acetylsalicylic acid (ASA) and two emclopidogrel/em drugs on residual ..."
 
Vol 9, No 6 (2013) THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) Abstract  similar documents
V. A. Sulimov
"... , coupled with timely coronary angiography, and primary percutaneous coronary intervention (emPCI/em ..."
 
Vol 14, No 6 (2018) P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva
"... coronary syndrome (ACS) undergoing percutaneous coronary intervention (emPCI/em) are discussed in the article ..."
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
"... Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + emclopidogrel/em ..."
 
Vol 5, No 6 (2009) RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID Abstract  similar documents
N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
"... aggregometer. ASA emresistance/em was defined if the summarizing index of platelet aggregation (induced with ADP, 5 ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... , warfarin, ticlopidine and emclopidogrel/em are discussed. Study data on new antiplatelet drugs are given ..."
 
Vol 7, No 1 (2011) THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY Abstract  similar documents
V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev
"... Aim. To study therapeutic equivalence (efficacy, safety and tolerability) of original emclopidogrel/em ..."
 
Vol 14, No 2 (2018) WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
M. Yu. Gilyarov, Е. V. Konstantinova
"... of reperfusion and the selected treatment strategy. Due to some limitations in the use of emclopidogrel/em ..."
 
Vol 11, No 6 (2015) Nephrogenic factors of resistance to antihypertensive treatment in patients with essential hypertension Abstract  similar documents
N. V. Teplova, V. A. Lyusov, R. G. Oganov, E. M. Evsikov, R. A. Sharipov, M. H. Zhapoeva, E. G. Kurumlidu
"... HT stages 1-3, including 105 patients with stages 2-3 with the signs of treatment emresistance/em were ..."
 
Vol 10, No 6 (2014) PROGNOSTIC IMPACT OF COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED HYPONATREMIA IN PATIENTS WITH DECOMPENSATED HEART FAILURE Abstract  similar documents
D. Yu. Shchekochikhin, Ph. Yu. Kopylov, N. L. Kozlovskaya, A. L. Syrkin
"... or less. Several outcomes were analyzed: mortality, transfer to intensive care unit (ICU), emresistance/em ..."
 
Vol 7, No 3 (2011) MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko
"... Aim. To study a rate of emclopidogrel/em use in patients having indications for emclopidogrel/em therapy ..."
 
Vol 9, No 6 (2013) THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY Abstract  similar documents
A. V. Shulkin, E. N. Yakusheva, N. M. Popova
"... agents and anticoagulants. Determination of C3435T polymorphism of multidrug emresistance/em gene (MDR1 ..."
 
Vol 13, No 6 (2017) CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE Abstract  similar documents
A. I. Akhmetova, E. B. Kleimenova, D. A. Sychev, O. V. Parshina, L. P. Yashina
"... .5%) patients received emclopidogrel/em, 17 (16.5%) – ticagrelor. After therapy correction based on genotype GA ..."
 
Vol 10, No 5 (2014) DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE Abstract  similar documents
G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov
"... .8% of patients also received combination of emclopidogrel/em and acetylsalicylic acid, but changed medicinal products ..."
 
Vol 9, No 2 (2013) ROLE OF INSULIN RESISTANCE AND ITS CORRECTION IN THE PROCESS OF VASCULAR AGING Abstract  similar documents
E. N. Dudinskaya, O. N. Tkacheva, I. D. Strazhesko, D. U. Akasheva
"... Insulin emresistance/em plays the main role in the pathogenesis of diabetes mellitus and its ..."
 
Vol 10, No 3 (2014) NEW METABOLIC INDEX USE POTENTIALITIES IN EVALUATION OF INSULIN RESISTANCE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
G. E. Roytberg, J. V. Dorosh, O. O. Sharkhun, T. I. Ushakova, E. A. Trubino
"... Early diagnostics of insulin emresistance/em (IR) is one of the methods of primary prevention of cardio ..."
 
Vol 11, No 2 (2015) THE INFLUENCE OF INSULIN RESISTANCE ON THE FORMATION AND PROGRESSION OF METABOLIC SYNDROME COMPONENTS (THE RESULTS OF A FIVE-YEAR STUDY) Abstract  similar documents
G. E. Roytberg, J. V. Dorosh, O. O. Sharkhun
"... of cardiovascular disease and type 2 diabetes. In the presence of insulin emresistance/em the effects of risk factors ..."
 
Vol 7, No 4 (2011) ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID Abstract  similar documents
I. N. Bokarev, L. V. Popova
"... . The evidence based clinical data on ASA treatment and the problem of antiplatelet therapy emresistance/em ..."
 
Vol 12, No 5 (2016) Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention Abstract  similar documents
E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva
"... pharmacological strategies, complications and adverse events following percutaneous coronary interventions (emPCI/em ..."
 
Vol 7, No 6 (2011) CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM Abstract  similar documents
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov
"... and thrombus in the LV aneurysm is considered in details. Successful percutaneous coronary intervention (emPCI/em ..."
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... Dual antiplatelet therapy, including emclopidogrel/em and aspirin, in a significant share of patients ..."
 
Vol 11, No 1 (2015) METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... and indapamide on insulin emresistance/em (IR), glucose, lipid and purine metabolism in patients with arterial ..."
 
Vol 6, No 4 (2010) EFFECTS OF ACUTE PHYSICAL EXERCISE OF VARYING INTENSITY ON LIPID METABOLISM IN MIDDLE AGED MEN Abstract  similar documents
G. E. Roytberg, I. D. Slastnikova, O. Ju. Dmitrieva, T. I. Ushakova
"... and in subjects with and without insulin emresistance/em. Results. Acute physical exercise of moderate and high ..."
 
Vol 8, No 4 (2012) RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS  similar documents
S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz
"... диабетом (СД) или ишемической болезнью сердца (ИБС) имеется emрезистентность/em к NO как на уровне тромбоцитов ..."
 
Vol 9, No 6 (2013) ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? Abstract  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein
"... emклопидогрелу/em и против 6,8% контроля). При многофакторном анализе emрезистентность/em к двойной антитромбоцитарной ..."
 
Vol 12, No 4 (2016) Resistant hypertension: epidemiology and risk factors Abstract  similar documents
I. E. Deneka, A. A. Svetankova, A. V. Rodionov
"... to treatment and non-rational therapy, there are other objective risk factors of emresistance/em. Three main ..."
 
Vol 2, No 2 (2006) COMPARISON OF EFFECTS OF ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY ON INSULIN RESISTANCE, ENDOTHELIUM FUNCTION, MARKERS OF INFLAMMATION AND PLATELET ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
M. N. Mamedov, T. V. Ektova, O. A. Litinskaya, T. Sh. Dzhakhangirov, O. V. Kosmatova
"... emresistance/em, endothelium function, markers of inflammation, and platelet activity in patients with metabolic ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... significance and therapeu- tic challenges overcoming emclopidogrel/em emresistance/em. Cardiovasc Diagn Ther 2013;3(1):23 ..."
 
Vol 7, No 2 (2011) EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY Abstract  similar documents
A. G. Avtandilov, I. I. Esenova, S. L. Petrosov
"... , insulin emresistance/em index and functional activity of beta-cells were performed. Anthropometric measurements ..."
 
Vol 13, No 1 (2017) EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 Abstract  similar documents
L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin
"... (emPCI/em), as well as hospital outcomes according to the AMI Register. Material and methods. 321 patients ..."
 
Vol 9, No 1 (2013) MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina, B. B. Gegenava
"... : diabetes mellitus, hyperglycemia, insulin emresistance/em, atherosclerosis, fibrosis, diabetic cardiomyopathy ..."
 
Vol 15, No 4 (2019) Resistant Hypertension: Questions and Contemporary Answers Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, K. K. Osadchiy
"... on the results of large-scale studies, risk factors are detected that allow to assess the risk for the emresistance/em ..."
 
Vol 13, No 4 (2017) HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? Abstract  similar documents
I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova
"... statins in high doses before percutaneous coronary interventions (emPCI/em) are presented in the review ..."
 
Vol 8, No 4 (2012) ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin
"... круга больных с ишемической болезнью сердца (ИБС) при добавлении emклопидогрела/em к аспирину [10, 11]. В ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... to daily maintenance) on long-term prognosis after elective percutaneous coronary intervention (emPCI/em ..."
 
Vol 7, No 1 (2011) NEW ANTIPLATELET DRUGS (PART 1) Abstract  similar documents
A. B. Sumarokov
"... описывается как emрезистентность/em к emклопидогрелу/em, коррелирует с тромбообразованием. emРезистентность/em к emклопидогрелу/em ..."
 
Vol 5, No 5 (2009) EFFECTS OF AMLODIPINE AND BISOPROLOL ON CAROTID AND VERTEBRAL BLOOD FLOW IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
E. D. Golovanova, N. N. Silaeva, D. Y. Kovalev
"... Aim. To compare influence of amlodipine and bisoprolol on peripheral vascular emresistance/em (PVR ..."
 
Vol 15, No 2 (2019) Association between Sympathetic Nervous System Activation, Obesity and Insulin Resistance Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova, A. V. Starodubova, Т. М. Оstroumova, D. A. Bondarenko
"... cardiovascular risk. The mechanisms of sympathetic overactivity in obesity, including insulin emresistance/em ..."
 
Vol 7, No 5 (2011) NEW ANTIPLATELET DRUGS. PART 2 Abstract  similar documents
A. B. Sumarokov
"... - лирования. Наличие emрезистентности/em к emклопидогрелу/em никак не отражалось на ответе пациента на терапию ..."
 
Vol 7, No 4 (2011) VASCULAR BED PECULIAR PROPERTIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION. ROLE OF ANTIPLATELET THERAPY Abstract  similar documents
L. A. Haisheva, S. V. Shlyk
"... of revealed disorders with antiplatelet agent — emclopidogrel/em 75 mg/day. Material and methods. 40 patients ..."
 
Vol 11, No 2 (2015) CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva
"... antiplatelet drugs (acetylsalicylic acid and emclopidogrel/em) and heparin. There were not any reasons ..."
 
Vol 8, No 2 (2012) IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? Abstract  similar documents
D. V. Nebieridze, T. V. Kamyshova
"... antihypertensive therapy is discussed. Moxonidine advantages, namely positive effects on insulin emresistance/em ..."
 
Vol 10, No 2 (2014) THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
L. V. Kremneva, O. V. Abaturova, S. V. Shalaev
"... present- ed. Key words: metabolic syndrome, insulin emresistance/em, arterial hypertension, antihypertensive ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... lipid-lowering therapy and can be considered as a predictor of emresistance/em to statins.  ..."
 
Vol 9, No 5 (2013) CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. N. Kushnarenko, A. V. Govorin
"... as fasting insulin blood level was determined by immunoenzyme method. Insulin-emresistance/em index (HOMA-IR ..."
 
Vol 3, No 4 (2007) THE PECULIARITIES OF CEREBRAL BLOOD FLOW IN PATIENTS WITH CHRONIC HEPATITIS Abstract  similar documents
V. E. Kulikov, B. B. Fishman, A. V. Volkov, G. S. Malyutin, G. I. Shvartsman
"... rate of blood flow in the medium cerebral arteries and decrease in emresistance/em index (0,55±0 ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... + emclopidogrel/em) can be prescribed to elderly patients with cardiovascular comorbidity who are deemed unsuitable ..."
 
Vol 15, No 2 (2019) The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention Abstract  similar documents
A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov
"... is emclopidogrel/em. It has been proven that the use of emclopidogrel/em to date not always reduces the risk of development ..."
 
Vol 9, No 3 (2013) EPICARDIAL FAT: A STRIKER OR A SPARE? Abstract  similar documents
O. M. Drapkina, O. N. Korneeva, Yu. S. Drapkina
"... heart disease, insulin emresistance/em, epicardial fat, waist circumference, cardiovascular risk. Ration ..."
 
Vol 4, No 3 (2008) ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS Abstract  similar documents
V. A. Sulimov
"... (Тиклид) b. emКлопидогрель/em (Плавикс) 3. Блокаторы IIb/IIIa гликопротеино- вых рецепторов тромбоцитов a ..."
 
Vol 15, No 4 (2019) Antimicrobial Treatment of Infective Endocarditis, Caused by Enterococcus Faecalis Abstract  PDF (Eng)  similar documents
E. V. Shikh, T. E. Morozova, V. N. Drozdov, N. B. Lazareva, D. A. Shatsky, T. B. Andrushchyshina, M. V. Lukina, O. A. Vartanova
"... studies report of a high level of emresistance/em of enterococcal strains to beta-lactam antibacterial drugs ..."
 
Vol 7, No 6 (2011) PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES Abstract  similar documents
R. M. Magdeev, O. V. Reshetko, E. Y. Rudnichenko, N. V. Furman, P. V. Dolotovskaya, T. Y. Grozdova, L. N. Volkova
"... , and emclopidogrel/em was not prescribed. At the same hospital clotting time was determined for monitoring of heparin ..."
 
Vol 12, No 1 (2016) Acute coronary syndrome and renal dysfunction Abstract  similar documents
F. I. Belyalov
"... /мин/1,73 м2) 1 (≥90) 2 (60-89) 3 (30-59) 4 (15-29) 5 (15) Аспирин + + + + + emКлопидогрел/em ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... ), с чем связано ее частое при- менение у лиц с данными нозологическими формами [2-4]. emКлопидогрел/em в ..."
 
Vol 13, No 4 (2017) FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION Abstract  similar documents
V. E. Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva
"... in the hemispheric asymmetry of the average linear flow rate up to 33.9±10.5%, reduction in emresistance/em ..."
 
Vol 7, No 5 (2011) THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman
"... - тельного риска смерти с 12 до 25% [7]. Пациенты, самостоятельно прекратившие принимать emклопидогрел/em в ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... . 51.8% of respondents recommend a combination of acetylsalicylic acid and emclopidogrel/em ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... in trials and proven efficacy in the prevention of stroke/systemic embolism, the use of emclopidogrel/em ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... pharmacies. Among antiplatelet agents, aspirin was available in most pharmacies, and emclopidogrel/em was mostly ..."
 
Vol 14, No 6 (2018) Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice Abstract  PDF (Eng)  similar documents
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova
"... (3.8%) patients. Aspirin was the only antiplatelet agent in 3 cases and emclopidogrel/em – in one case ..."
 
Vol 7, No 2 (2011) COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE Abstract  similar documents
V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko
"... on reperfusion strategy (no reperfusion, percutaneous coronary intervention (emPCI/em), prehospital thrombolysis ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... Aim. To compare the dynamics of intrarenal vascular emresistance/em (IRVR), circadian blood pressure ..."
 
Vol 7, No 4 (2011) PROTHROMBOTIC POLYMORPHISMS AND LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Abstract  similar documents
A. L. Komarov, O. O. Shahmatova, D. V. Rebrikov, D. Yu. Trophimov, T. I. Kotkina, T. A. Ilyushenko, A. D. Deev, E. P. Panchenko
"... (acetyl- salicylic acid, emclopidogrel/em or their combination), β-block- ers, ACE-inhibitors, and statins if ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... treatment of IHD / Динамика лекарственной терапии при ИБС acetylsalicylic acid (ASA) and emclopidogrel/em (level ..."
 
Vol 14, No 1 (2018) COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
"... receptors (AMCR), diuretics, oral anticoagulants, emclopidogrel/em increased (p0.05). In the structure ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... with emclopidogrel/em (up to 5.4%) was registered at the second stage of the study. Over a five-year period bisoprolol ..."
 
Vol 13, No 2 (2017) TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1 Abstract  similar documents
M. Yu. Gilyarov, M. O. Zheltoukhova, E. V. Konstantinova, M. D. Muksinova, L. S. Muradova, A. P. Nesterov, A. E. Udovichenko
"... . The incidence of percutaneous coronary intervention (emPCI/em) and coronary angiography (CAG) significantly increased ..."
 
Vol 13, No 1 (2017) CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION Abstract  similar documents
V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova
"...   intervention (emPCI/em), were included into the study. Telemetry ECG was performed before  and after emPCI/em ..."
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... emresistance/em, obesity, dyslipidemia is also covered. The evidence base for the use of telmisartan as a drug ..."
 
Vol 8, No 1 (2012) GENDER DISTINCTIONS OF MICROALBUMINURIA AND ITS RELATION TO INTRARENAL HEMODYNAMIC AND LEPTIN LEVEL IN ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, J. N. Rodionova
"... genders demonstrated higher both emresistance/em index (RI) and pulsatility index (PI). Gender differences ..."
 
Vol 8, No 3 (2012) EFFECT OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION ON CEREBRAL HEMODYNAMICS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (THE RESULTS OF OBSERVATIONAL STUDIES) Abstract  similar documents
V. E. Kulikov, M. Je. Hapman, P. A. Barov, M. A. Toneeva, V. A. Sergievskaja
"... (индекс emрезистентности/em 0,63-0,76 и 0,49-0,43 у.е., соответственно). Заключение. У пациентов в остром ..."
 
Vol 9, No 1 (2013) OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
"... : antiplatelet agents – in 60.4% of the cases (584 patients received acetylsalicylic acid and 20 – emclopidogrel/em ..."
 
Vol 5, No 5 (2009) ANTIAGGREGANT THERAPY OVERCOMES LIMITS Abstract  similar documents
I. Andreeva
"... На отечественном фармацевтическом рынке по- явился новый европейский emклопидогрел/em — Эгитромб (Эгис ..."
 
1 - 100 of 361 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)